GRI
GRI Bio, Inc.
Key Financials
Operating Income
$-11977000
↓ 45.4%
Revenue
$0
↓ 100.0%
Net Income
$-11956000
↓ 45.7%
EPS (Diluted)
$-121.80
↓ 120.6%
Total Assets
$8.7M
↑ 51.0%
Shareholders' Equity
$6.0M
↑ 49.0%
Total Liabilities
$2.7M
↑ 55.7%
Cash & Equivalents
$8.2M
↑ 63.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GRI |
| Company Name | GRI Bio, Inc. |
| CIK | 1824293 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (619) 400-1171 |